Abstract Submission is Officially Open:

Click here to submit your abstract

Abstract submission deadline

28 April, 2026

Notifications to submitters will be emailed

by end of June, 2026

The International Scientific Programme Committee invites you to contribute to the programme by submitting an abstract for possible inclusion in the 21st International Congress on Infectious Diseases (ICID) 2026.

Please follow the abstract guidelines below, to help you through the submission process.

Abstract Guidelines

Abstract submission and presentation rules

  • The presenting author of Orals and Poster presentations are expected to register by the deadline for in-person presentation at the Congress.
  • The presenting author is required to ensure that all co-authors are aware of and approve the content of the abstract before submission.
  • Maximum abstract submission and presentations per person: 5
  • All abstracts submitted via the online submission form before the deadline will be forwarded to the Abstract Review Committee for review.
  • An abstract can be submitted if it has not been previously accepted for publication or presented at another Congress before the ICID 2026 Congress dates.
  • All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication.
  • Abstracts submitted by fax or e-mail will not be accepted.
  • Please do not submit multiple copies of the same abstract.
  • After submission of the abstract, a confirmation email will be sent to the abstract submitter. To receive this important communication, please ensure that emails from noreply@ctimeetingtech.com and not considered spam by your e-mail provider.
  • For all authors, when creating your user and participation profile to attend the congress, use the same e-mail that was used during the abstract submission. If a different profile is used the abstract will not be linked to your profile.
  • You will receive email confirmation that your abstract has been received, indicating the abstract number which it has been allocated. Please refer to this abstract number in all correspondence regarding the abstract.
  • For questions about the submission, please contact: icid_abstracts@kenes.com
  • Instructions for preparation of oral or poster presentations will be sent together with acceptance notifications.
  • The Committee will endeavor to schedule abstracts according to authors’ preferences but reserve the right to decide on the final form of presentation.
  • For each abstract, an author is expected to register for the Congress. Presenting authors must register by the Early Bird registration deadline 30 July, 2026.
  • All accepted and presented abstracts for which a presenting author is registered and has paid the registration fee by the deadline will be scheduled for presentation and included in the online Congress Scientific Programme. Abstracts without a registered author by 30 July 2026 will be excluded from the final Scientific Programme.
  • High scoring abstracts for which a presenting author is registered and has paid the registration fee will be published as a supplement of the International Journal of Infectious Diseases (IJID) after the Congress.

Writing & submitting your abstract

Please follow the guidance below when writing and submitting your abstract. Failure to do so may result in your abstract receiving a low grade making it unsuitable for further consideration.

A brief title that clearly indicates the content of the contribution (maximum of 30 words).

Please avoid abbreviations in the abstract title. Abbreviations may be used if they refer to gene names using the standardized nomenclature, and in the body of the abstract if defined when first used. Do not use capitals or capitalize words that are not nouns.

Example:

Title: This is an important African contribution to the field in terms of the APOL1 gene

Diagrams, illustrations, tables, references and graphics are NOT permitted.

Abstracts under all topics and without exception should be structured under the following section headings; Aim, Methods, Results, Conclusion (maximum of 300 words).

Check grammar and spelling, sentence construction and punctuation before submission. Ensure that abbreviations are defined when used for the first time and then use the abbreviation in the rest of the abstract. Only use abbreviations if the term is used two or more times.

Note: Abstracts not submitted in the format above will not be eligible for review.

  • The abstract should be as informative as possible
  • Aim: State background to the study and the aim of the study
  • Methods: shortly describe methods used
  • Results: summarize results obtained, report quantitative data, confidence intervals, and p values for comparisons
  • Conclusions: state conclusions reached

Presentation type – please choose from one of the following:

  • Oral presentation
  • Poster presentation

Author and co-authors’ details:

  • Full first and family name(s)
  • Affiliation details: department, institution / hospital, city, state (if relevant), country

Abstract topic – Abstracts must be allocated to a specific topic for the Scientific Program. Please choose from the list of topics.

Abstract may be reallocated by the scientific committee, in order to organize consistent sessions

This support opportunity is a part of the abstract submission process. You cannot apply for this Grant without submitting an abstract.

Before applying for the Early Career Researcher travel grant, please ensure you fulfil the requirements and attach all required documents during the abstract submission:

– Please clarify in max 300 words why you would like to attend the 21st ICID Congress.

– Proof of age 40 years and below by the submission date. Please attach a document that proves your birth date and country of origin (ie, passport/ID card, birth certificate, driving license, etc.).  The document must include English or be translated into English.
– An undergraduate or postgraduate (Masters/PhD) student or a scientist who has received their highest degree (BSc, MSc, or PhD) within the past five years. Please attach a letter of recommendation signed by your department head or a supervisor with an indication of their affiliation and role. The letter must be written in English.
– Confirm you have not received ISID-funded support to attend the past two (2) ICID Congresses (Kuala Lumpur in 2022/Cape Town in 2024)”

For any further information, please contact: icid_abstracts@kenes.com

Late Breaking abstract submission will be between 4-18 August, 2026. Please note: late-breaking abstract submission is not an extension to the regular submission, but this abstract should contain new information with results that were not yet known\fully available on the regular abstract submission deadline.

These abstracts must include new decisive and original results obtained after the submission deadline. The justification of the late breaking must be added as a commentary upon submission